Amanta Healthcare Quarterly Results
Amanta Healthcare quarterly results. In 2026, Amanta Healthcare (AMANTA) reported revenue ₹294 Cr and net profit ₹15 Cr. Review Amanta Healthcare P/E valuation to evaluate earnings-based valuation against sector peers.
AMANTA Quarterly Results — Revenue, Profit & EPS Highlights
Amanta Healthcare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Amanta Healthcare share price today.
- Revenue of ₹291 Cr in March 2026 (+0.0% vs March 2026, +5.4% vs March 2025)
- Net Profit of ₹15 Cr in March 2026 (+0.0% vs March 2026, +36.4% vs March 2025)
- EBITDA of ₹63 Cr in March 2026 (+0.0% vs March 2026)
- Operating Margin of 21.0% in March 2026 (+0.0pp vs March 2026)
- Earnings Per Share of ₹4.33 in March 2026 (+0.0% vs March 2026)
Amanta Healthcare Quarterly Results — Revenue, EBITDA, Net Profit & EPS
AMANTA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | 2026 | March 2026 | March 2025 | March 2024 | March 2023 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 294 | 291 | 276 | 282 | 263 | 1.0% | - |
| Net Profit (₹ Cr) | 15 | 15 | 11 | 4 | -2 | - | - |
| EBITDA (₹ Cr) | 60 | 63 | 61 | 59 | 56 | - | - |
| EPS (₹) | 4.20 | 4.33 | 3.71 | 1.35 | -0.79 | - | - |
| Operating Margin (%) | 20.0% | 21.0% | 22.0% | 21.0% | 20.0% | - | - |
AMANTA Share Price Trend — 1-Year Movement Across Quarterly Results
Amanta Healthcare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check AMANTA market cap trends to track the company's total market size over time.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
AMANTA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Amanta Healthcare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹421,995.00 Cr | 1748.0 | 15,018 | 2,710 | -5.6% | - | 18.0% | 154.7 |
|
Divis Laboratories
Mar 2026 |
₹241,231.30 Cr | 8950.0 | 2,986 | 751 | -5.0% | - | 25.2% | 316.1 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4524.4 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 393.1 |
|
Laurus Labs
Mar 2026 |
₹111,790.60 Cr | 1970.0 | 1,823 | 282 | -10.5% | - | 15.5% | 381.0 |
|
Zydus Life Science
Mar 2026 |
₹111,111.95 Cr | 1129.4 | 7,569 | 1,341 | -4.3% | - | 17.7% | 89.3 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores